The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
Open accessAbstract
Doxorubicin (DOX), or Adriamycin, an anthracycline antibiotic discovered serendipitously as a chemotherapeutic drug several decades ago, is still one of the most effective drugs for treating various adult and pediatric cancers (breast cancer, Hodgkin's disease, lymphoblastic leukemia). However, one of the major side effects of the continuous use of DOX is dose-dependent, long-term, and potentially lethal cardiovascular toxicity (congestive heart failure and cardiomyopathy) in cancer survivors many years after cessation of chemotherapy. In addition, predisposition to cardiotoxicity varied considerably among individuals. The long-held notion that DOX cardiotoxicity is caused by reactive oxygen species formed from the redox-cycling of DOX semiquinone lacks rigorous proof in a chronic animal model, and administration of reactive oxygen species detoxifying agents failed to reverse DOX-induced cardiac problems. In this review, I discuss the pros and cons of the reactive oxygen species pathway as a primary or secondary mechanism of DOX cardiotoxicity, the role of topoisomerases, and the potential use of mitochondrial-biogenesis-enhancing compounds in reversing DOX-induced cardiomyopathy. New approaches for well-designed clinical trials that repurpose FDA-approved drugs and naturally occurring polyphenolic compounds prophylactically to prevent or mitigate cardiovascular complications in both pediatric and adult cancer survivors are needed. Essentially, the focus should be on enhancing mitochondrial biogenesis to prevent or mitigate DOX-induced cardiotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis as a target for protection against cardiomyopathy
Fang, X., Wang, H., Han, D., Xie, E., Yang, X., Wei, J., Gu, S., Gao, F., Zhu, N., Yin, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821022116 · Cited by 2,127
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Doxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845
Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response
Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K., & Young, R. C. (1977) · Science · doi:10.1126/science.877547 · Cited by 1,111
Adriamycin: A New Anticancer Drug with Significant Clinical Activity
BLUM, R. H., & CARTER, S. K. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-2-249 · Cited by 1,057
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 878
Recent insights into the function of autophagy in cancer
Amaravadi, R., Kimmelman, A. C., & White, E. (2016) · Genes & Development · doi:10.1101/gad.287524.116 · Cited by 813
The Anthracycline Antineoplastic Drugs
Young, R. C., Ozols, R. F., & Myers, C. E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107163050305 · Cited by 793
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V. M., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Delivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Prevention of Anthracycline-Induced Cardiotoxicity
Vejpongsa, P., & Yeh, E. T. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1167 · Cited by 671
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
Swain, S. M., Whaley, F. S., Gerber, M. C., Weisberg, S., York, M., Spicer, D., Jones, S. E., Wadler, S., Desai, A., Vogel, C., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1318 · Cited by 664
Davies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
Lyu, Y. L., Kerrigan, J. E., Lin, C.-P., Azarova, A. M., Tsai, Y.-C., Ban, Y., & Liu, L. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1649 · Cited by 612
Austin, S., & St-Pierre, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.113662 · Cited by 608
A Phase 3 Trial of l -Glutamine in Sickle Cell Disease
Niihara, Y., Miller, S. T., Kanter, J., Lanzkron, S., Smith, W. R., Hsu, L. L., Gordeuk, V. R., Viswanathan, K., Sarnaik, S., Osunkwo, I., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715971 · Cited by 563
Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin
Goodman, J., & Hochstein, P. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(77)80048-x · Cited by 543
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
Henriksen, P. A. (2018) · Heart · doi:10.1136/heartjnl-2017-312103 · Cited by 536
Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment
Lenneman, C. G., & Sawyer, D. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.303633 · Cited by 469
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Li, D. L., Wang, Z. V., Ding, G., Tan, W., Luo, X., Criollo, A., Xie, M., Jiang, N., May, H., Kyrychenko, V., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017443 · Cited by 464
Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., & St Clair, D. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118909 · Cited by 459
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
Pillai, V. B., Samant, S., Sundaresan, N. R., Raghuraman, H., Kim, G., Bonner, M. Y., Arbiser, J. L., Walker, D. I., Jones, D. P., Gius, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7656 · Cited by 445
Anthracycline Antibiotic Augmentation of Microsomal Electron Transport and Free Radical Formation
BACHUR, N. R., GORDON, S. L., & GEE, M. V. (1977) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12453-x · Cited by 373
Kotamraju, S., Konorev, E. A., Joseph, J., & Kalyanaraman, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003890200 · Cited by 372
Self-citationSelective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
Chemotherapy and Cardiotoxicity in Older Breast Cancer Patients: A Population-Based Study
Doyle, J. J., Neugut, A. I., Jacobson, J. S., Grann, V. R., & Hershman, D. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5841 · Cited by 335
Kalyanaraman, B., Perez-Reyes, E., & Mason, R. P. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90142-7 · Cited by 317
Self-citationAutophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Koleini, N., & Kardami, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16944 · Cited by 301
The multiple roles of autophagy in cancer
Rosenfeldt, M. T., & Ryan, K. M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr031 · Cited by 300
Adriamycin (NSC 123127) cardiomyopathy. An overview with determination of risk factors
Minow, R. A., Benjamin, R. S., & Gottlieb, J. A. (1975) · Cited by 274
Saad, S. Y., Najjar, T. A., & Al-Rikabi, A. C. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0769 · Cited by 259
Clinical spectrum of anthracycline antibiotic cardiotoxicity.
Bristow, M. R., Billingham, M. E., Mason, J. W., & Daniels, J. R. (1978) · PubMed · Cited by 250
Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex
Myers, C. E., Gianni, L., Simone, C. B., Klecker, R., & Greene, R. (1982) · Biochemistry · doi:10.1021/bi00537a001 · Cited by 239
Treatment-related cardiotoxicity in survivors of childhood cancer
Lipshultz, S. E., Cochran, T. R., Franco, V. I., & Miller, T. L. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.195 · Cited by 233
Vejpongsa, P., & Yeh, E. T. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.201 · Cited by 225
Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., Bennett, B., & Zielonka, J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.012 · Cited by 221
Self-citationLebrecht, D., Setzer, B., Ketelsen, U.-P., Haberstroh, J., & Walker, U. A. (2003) · Circulation · doi:10.1161/01.cir.0000093196.59829.df · Cited by 219
Dhingra, R., Margulets, V., Chowdhury, S. R., Thliveris, J., Jassal, D., Fernyhough, P., Dorn, G. W., & Kirshenbaum, L. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414665111 · Cited by 217
Role of iron in anthracycline cardiotoxicity: new tunes for an old song?
MINOTTI, G., CAIRO, G., & MONTI, E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.199 · Cited by 214
Late anthracycline cardiotoxicity after childhood cancer: A prospective longitudinal study
Sorensen, K., Levitt, G. A., Bull, C., Dorup, I., & Sullivan, I. D. (2003) · Cancer · doi:10.1002/cncr.11274 · Cited by 214
New signal transduction paradigms in anthracycline-induced cardiotoxicity
Ghigo, A., Li, M., & Hirsch, E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.021 · Cited by 194
Abdullah, C. S., Alam, S., Aishwarya, R., Miriyala, S., Bhuiyan, M. A. N., Panchatcharam, M., Pattillo, C. B., Orr, A. W., Sadoshima, J., Hill, J. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37862-3 · Cited by 193
Pillai, V. B., Kanwal, A., Fang, Y. H., Sharp, W. W., Samant, S., Arbiser, J., & Gupta, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.16133 · Cited by 192
Gut Microbiota Shapes the Efficiency of Cancer Therapy
Ma, W., Mao, Q., Xia, W., Dong, G., Yu, C., & Jiang, F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01050 · Cited by 192
Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage
Geisberg, C. A., & Sawyer, D. B. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0146-y · Cited by 189
Levis, B. E., Binkley, P. F., & Shapiro, C. L. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30535-1 · Cited by 184
Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-Q
Chandran, K., Aggarwal, D., Migrino, R. Q., Joseph, J., McAllister, D., Konorev, E. A., Antholine, W. E., Zielonka, J., Srinivasan, S., Avadhani, N. G., et al. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.042 · Cited by 170
Self-citationCardiotoxicity in Childhood Cancer Survivors: Strategies for Prevention and Management
Harake, D., Franco, V. I., Henkel, J. M., Miller, T. L., & Lipshultz, S. E. (2012) · Future Cardiology · doi:10.2217/fca.12.44 · Cited by 166
Hydroxyl radical production and DNA damage induced by anthracycline‐iron complex
Muindi, J. R., Sinha, B. K., Gianni, L., & Myers, C. E. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81130-8 · Cited by 150
Oxidative metabolism in cancer growth
Ristow, M. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232892.43921.98 · Cited by 145
Chemical, Biological and Clinical Aspects of Dexrazoxane and Other Bisdioxopiperazines
Hasinoff, B. B., Hellmann, K., Herman, E., & Ferrans, V. J. (1998) · Current Medicinal Chemistry · doi:10.2174/0929867305666220314194045 · Cited by 141
Lebrecht, D., Geist, A., Ketelsen, U., Haberstroh, J., Setzer, B., & Walker, U. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707294 · Cited by 136
PGC-1: The Energetic Regulator in Cardiac Metabolism
Di, W., Lv, J., Jiang, S., Lu, C., Yang, Z. P., Ma, Z., Hu, W., Yang, Y., & Xu, B. (2018) · Current Issues in Molecular Biology · doi:10.21775/cimb.028.029 · Cited by 134
Lebrecht, D., Kokkori, A., Ketelsen, U., Setzer, B., & Walker, U. A. (2005) · The Journal of Pathology · doi:10.1002/path.1863 · Cited by 133
Pointon, A., Walker, T. M., Phillips, K. M., Luo, J., Riley, J., Zhang, S., Parry, J. D., Lyon, J. J., Marczylo, E. L., & Gant, T. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012733 · Cited by 133
Mechanisms of toxic cardiomyopathy
Hantson, P. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1497172 · Cited by 129
Bellinger, A. M., Arteaga, C. L., Force, T. L., Humphreys, B. D., Demetri, G. D., Druker, B. J., & Moslehi, J. J. (2015) · Circulation · doi:10.1161/circulationaha.115.010484 · Cited by 125
Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?
Hasinoff, B. B., & Herman, E. H. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0023-3 · Cited by 123
Svingen, B. A., & Powis, G. (1981) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(81)90263-0 · Cited by 122
Early Detection of Doxorubicin Cardiomyopathy Using Two-Dimensional Strain Echocardiography
Migrino, R. Q., Aggarwal, D., Konorev, E. A., Brahmbhatt, T., Bright, M., & Kalyanaraman, B. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2007.07.018 · Cited by 118
Self-citationCheng, G., Zielonka, M., Dranka, B. P., Kumar, S. N., Myers, C. R., Bennett, B., Garces, A. M., Machado, L. G. D. D., Thiébaut, D., Ouari, O., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003044 · Cited by 118
Self-citationEffects of Polyphenols on Thermogenesis and Mitochondrial Biogenesis
dos Santos, T. W., Pereira, Q. C., Teixeira, L., Gambero, A., Villena, J. A., & Ribeiro, M. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092757 · Cited by 117
Munroe, M. E., Arbiser, J. L., & Bishop, G. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.753 · Cited by 112
Bacterial Inactivation of the Anticancer Drug Doxorubicin
Westman, E. L., Canova, M. J., Radhi, I. J., Koteva, K. K., Kireeva, I., Waglechner, N., & Wright, G. D. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.011 · Cited by 104
Dutta, D., Xu, J., Dirain, M. L. S., & Leeuwenburgh, C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.011 · Cited by 103
Altered glutamine metabolism in platinum resistant ovarian cancer
Hudson, C. D., Savadelis, A., Nagaraj, A. B., Joseph, P. L., Avril, S., DiFeo, A. V., & Avril, N. E. (2016) · Oncotarget · doi:10.18632/oncotarget.9317 · Cited by 102
N europrotective effects of honokiol: from chemistry to medicine
Talarek, S., Listos, J., Barreca, D., Tellone, E., Sureda, A., Nabavi, S. F., Braidy, N., & Nabavi, S. M. (2017) · BioFactors · doi:10.1002/biof.1385 · Cited by 94
Averill‐Bates, D. A., & Winterbourn, C. C. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81222-2 · Cited by 91
Translating Stem Cell Research to Cardiac Disease Therapies
Rosen, M. R., Myerburg, R. J., Francis, D. P., Cole, G. D., & Marbán, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1175 · Cited by 90
An electron spin resonance study of the reduction of peroxides by anthracycline semiquinones
Kalyanaraman, B., Sealy, R. C., & Sinha, B. K. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90270-8 · Cited by 90
Self-citationExercise Prevention of Cardiovascular Disease in Breast Cancer Survivors
Kirkham, A. A., & Davis, M. K. (2015) · Journal of Oncology · doi:10.1155/2015/917606 · Cited by 89
Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
Coelho, A. R., Martins, T. R., Couto, R., Deus, C. M., Pereira, C. V., Simões, R. F., Rizvanov, A. A., Silva, F. S. G., Cunha‐Oliveira, T., Oliveira, P. J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.030 · Cited by 83
Schwarz, E. R., Pollick, C., Dow, J., Patterson, M., Birnbaum, Y., & Kloner, R. A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00009-1 · Cited by 76
Huang, L., Zhang, K., Guo, Y., Huang, F., Yang, K., Chen, L., Huang, K., Zhang, F., Long, Q., & Yang, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-12095-y · Cited by 70
Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity
Gutiérrez, P. L., Gee, M. V., & Bachur, N. R. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90572-6 · Cited by 67
Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure
Kärkkäinen, O. K., Tuomainen, T., Mutikainen, M., Lehtonen, M., Ruas, J. L., Hanhineva, K., & Tavi, P. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy155 · Cited by 67
Anthracycline-Induced Cardiotoxicity in Children with Cancer
Iarussi, D., Indolfi, P., Casale, F., et al. (2005) · Pediatric Drugs · doi:10.2165/00148581-200507020-00001 · Cited by 66
Glutamine Protects against Doxorubicin-Induced Cardiotoxicity
Cao, Y., Kennedy, R. H., & Klimberg, V. S. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5677 · Cited by 65
Kalyanaraman, B., Morehouse, K. M., & Mason, R. P. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90023-c · Cited by 64
Self-citationKonorev, E. A., Kotamraju, S., Zhao, H., Kalivendi, S. V., Joseph, J., & Kalyanaraman, B. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00989-9 · Cited by 63
Self-citationDu, Q., Zhu, B., Zhai, Q., et al. (2017) · PubMed · Cited by 62
Boutagy, N. E., Wu, J., Cai, Z., Zhang, W., Booth, C. J., Kyriakides, T. C., Pfau, D. J., Mulnix, T., Liu, Z., Miller, E. J., et al. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.02.003 · Cited by 62
Dickey, J. S., Gonzalez, Y., Aryal, B., Mog, S., Nakamura, A. J., Redon, C. E., Baxa, U., Rosen, E., Cheng, G., Zielonka, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070575 · Cited by 60
Self-citationCancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity
Zhang, J.-C., Chen, W., Alvarez, J. B., Jia, K. Q., Shi, L., Wang, Q., Zou, N., He, K., & Zhu, H. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0062-2 · Cited by 56
Hasinoff, B. B., Schroeder, P. E., & Patel, D. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.670 · Cited by 50
Role of iron in adriamycin biochemistry.
Myers, C., Gianni, L., Zweier, J. L., Muindi, J. R., Sinha, B. K., & Eliot, H. M. (1986) · PubMed · Cited by 49
Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity
Pizarro, M., Troncoso, R., Martínez, G. J., Chiong, M., Castro, P., & Lavandero, S. (2016) · Toxicology · doi:10.1016/j.tox.2016.09.011 · Cited by 49
Cui, N., Wu, F., Lu, W., Bai, R., Ke, B., Liu, T., Li, L., Lan, F., & Cui, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14346 · Cited by 49
Sheng, C. C., Amiri‐Kordestani, L., Palmby, T. R., Force, T. L., Hong, C. C., Wu, J. C., Croce, K., Kim, G., & Moslehi, J. J. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.05.008 · Cited by 43
Kalyanaraman, B., Hardy, M., & Zielonka, J. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0063-0 · Cited by 38
Self-citationThe role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction
Dolinsky, V. W. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0316 · Cited by 38
Anthracycline and Peripartum Cardiomyopathies
Cowgill, J. A., Francis, S. A., & Sawyer, D. B. (2019) · Circulation Research · doi:10.1161/circresaha.119.313577 · Cited by 38
Anthracycline-Induced Cardiomyopathy: Secrets and Lies
Farmakis, D. T., Mantzourani, M., & Filippatos, G. S. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1172 · Cited by 36
Sonowal, H., Pal, P. B., Shukla, K., Saxena, A., Sk, S., & Ramana, K. V. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.018 · Cited by 35
Xue, H., Ren, W., Denkinger, M., Schlotzer, E., & Wischmeyer, P. E. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115581838 · Cited by 33
Adriamycin-associated cardiomyopathy
Hardaway, B. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000617 · Cited by 32
Mitochondrial cytochrome c oxidase as a target site for daunomycin in K-562 cells and heart tissue.
Papadopoulou, L. C., & Tsiftsoglou, A. S. (1993) · PubMed · Cited by 29
Jirkovský, E., Jirkovská, A., Bureš, J., Chládek, J., Lenčová-Popelová, O., Stariat, J., Pokorná, Z., Karabanovich, G., Roh, J., Kollárová-Brázdová, P., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244848 · Cited by 22
Cited by
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 810
Wang, Y., Yan, S., Liu, X., Deng, F., Wang, P., Yang, L., Hu, L., Huang, K., & He, J. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00990-5 · Cited by 315
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
Sheibani, M., Azizi, Y., Shayan, M., Nezamoleslami, S., Eslami, F., Farjoo, M. H., & Dehpour, A. R. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09721-1 · Cited by 276
Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.10.003 · Cited by 257
Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy
Wang, Y., Huo, Y., Zhao, C., Liu, H., Shao, Y., Zhu, C., An, L., Chen, X., & Chen, Z. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.02.015 · Cited by 84
Metadata
- Authors
- Kalyanaraman, B.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 29
- Pages
- 101394
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W2990916932
- Cited by
- 326
- References
- 99
- FWCI
- 23.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.